Lung Cancer
Recent studies by C. Butts and co-authors add new data to lung cancer findings
Published in Vaccine Weekly, December 29th, 2010
2010 DEC 29 -- According to a study from Edmonton, Canada, "BLP25 liposome vaccine (L-BLP25) is an innovative therapeutic cancer vaccine designed to induce an immune response resulting in elimination of tumor cells expressing the MUC1 antigen, which is overexpressed in non small-cell lung cancer (NSCLC). Manufacturing modifications have produced subtle changes to the lipid A acyl chain composition of L-BLP25."
"This open-label phase II study was conducted to evaluate the safety of the new formulation in patients with unresectable stage IIIA/IIIB NSCLC. Twenty-two patients received L-BLP25 1000 mu g every week for 8 weeks plus best supportive care....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-12-29)
More Articles from Vaccine Weekly
- Pediatric Vaccines
Fighting flu in newborns begins in pregnancy - Vaccines
Media Release - Refugees to receive gift of health care this holiday season - Health Insurance
18.3 million baby boomers could benefit from the Affordable Care Act - Bacterial Vaccines
Bioethics Commission calls for enhanced federal oversight in new field of synthetic biology - Bacterial Vaccines
Data on bacterial vaccines discussed by researchers at Ludwig-Maximilians University - Viral Vaccines
Data on viral vaccines published by investigators at University of Science and Technology, Research Center - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
